PREVALENCE OF MYCELIAL FUNGAL FORMS IN CHRONIC OTITIS MEDIA AT A TERTIARY CARE HOSPITAL

Main Article Content

Dr Pinki Kumari
Dr Jiwesh Kumar Thakur
Ramjanam Prasad
Dr Aditya Kumar Jha
Dr Chaitanya Konda
Dr Sai Ravi Kiran Biri
Dr Vijay Kumar

Keywords

Chronic Otitis Media, mycelial fungi, Aspergillus, fungal otitis media, prevalence, tertiary care hospital.

Abstract

Background: Chronic Otitis Media (COM) is a common condition associated with recurrent ear discharge, often involving bacterial or fungal infections. Mycelial fungi, particularly Aspergillus species, are frequently implicated in fungal otitis media, but their prevalence remains underreported in many regions.


Objective: This study aimed to determine the prevalence and species distribution of mycelial fungal infections in patients with COM at a tertiary care hospital.


Methods: A prospective, hospital-based observational study was conducted over a 9-month period in the Department of Microbiology at Gouri Devi Institute of Medical Sciences and Hospital, Durgapur,India. A total of 196 patients diagnosed with otomycosis were enrolled. Fungal isolates were identified through culture and microscopy. Demographic data, clinical symptoms, and predisposing factors were recorded and analyzed.


Results: Among the 196 patients, 132 were male and 64 were female, with the majority aged 21-30 years. A total of 109 patients had Acute Suppurative Otitis Media (ASOM), and 87 had Chronic Suppurative Otitis Media (CSOM). The most common symptoms were hearing loss (54.1%) and pruritus (34.8%). Fungal cultures revealed Aspergillus niger in 63.3% of cases, followed by Aspergillus flavus (18.3%), Aspergillus fumigatus (6.4%), and Candida species (2.7%). Key risk factors included self-cleaning of the ears (44.9%) and prior antimicrobial use (12.8%).


Conclusion: This study demonstrates a high prevalence of mycelial fungal infections in patients with COM, with Aspergillus niger being the most common pathogen. Early identification and appropriate antifungal treatment are essential for effective management. Increased awareness of fungal involvement in otitis media, particularly in high-risk patients, is crucial for improving outcomes.

Abstract 89 | PDF Downloads 26

References

1. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO.SENS Project. J AntimicrobChemother. 2010;65(3):471-477.
2. Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, et al. Emergence of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli. Int J Antimicrob Agents. 2012;39(3):197-206.
3. Hsu JT, Chen M, Lin W, et al. Emergence of Multidrug-Resistant Bacteria: A Global Perspective. Front Microbiol. 2020;11:1290.
4. Dierikx CM, van Duijkeren E, Schoormans A, et al. Monitoring Antimicrobial Resistance in Livestock. Vet Microbiol. 2013;162(1):1-12.
5. Laube H, Friese A, von Salviati C, Guerra B, Käsbohrer A, Kreienbrock L, et al. Antibiotic Resistance in Enterobacteriaceae from Food Animals. Foodborne Pathog Dis. 2013;10(6):505-511.
6. Gould IM, Bal AM. New antibiotic agents in the pipeline and how they will influence antibiotic resistance. Expert Rev Anti Infect Ther. 2017;15(4):261-266.
7. Harris PNB, Tambyah PA, Lye DC, et al. Antimicrobial resistance: the past, the present, and the future. Med J Aust. 2015;203(5):199-204.
8. Bush K, Jacoby GA. Extended-Spectrum Beta-Lactamases. Antimicrob Agents Chemother. 2010;54(3):969-976.
9. Paterson DL, Bonomo RA. Extended-Spectrum Beta-Lactamases: A Clinical Update. ClinMicrobiol Rev. 2005;18(4):657-686.
10. Tzeng YL, et al. Prevalence of ESBL-producing Enterobacteriaceae in Hospitalized Patients. Infect Control HospEpidemiol. 2020;41(2):224-230.
11. Kaur M, et al. Epidemiology of ESBL-producing Escherichia coli. J Glob Antimicrob Resist. 2018;13:103-108.
12. Gonzalez M, et al. AmpC Beta-Lactamases: A Review. J AntimicrobChemother. 2020;75(5):1141-1150.
13. Al-Tamini S, et al. The Role of Antimicrobial Stewardship Programs in Reducing Antibiotic Resistance. Infect PrevPract. 2019;1(2):100027.
14. Damato E, et al. Otomycosis: a review of 10 years' experience. J Laryngol Otol. 1964;78:1-9.
15. Bezjak M, et al. Fungal infections of the ear: a review of 10 years’ experience. ActaOtorhinolaryngol Ital. 1970;10(1):5-10.
16. Kaur R, et al. Epidemiology of otomycosis: a study from North India. J Glob Antimicrob Resist. 2018;13:103-108.
17. Fasunla AJ, et al. Otomycosis: a review of current literature. Ear Nose Throat J. 2016;95(8)
18. Yehia A, et al. Otomycosis: a clinical study of 100 cases. J Laryngol Otol. 1990;104(12):932-935.
19. Kurnatowski P, Filipiak K. Fungal infections in patients with chronic otitis media: a review of current literature. Mycoses. 2009;52(5):408-414.
20. Than S, et al. The role of fungi in chronic otitis media: a review of literature. J Laryngol Otol. 1980;94(2):145-149.
21. Mugliston T, et al. Fungal infections in chronic suppurative otitis media: a review of cases from a tertiary care center. J ClinMicrobiol. 1985;22(5):850-854.
22. Lucente F, et al. The role of fungi in chronic otitis media: an overview. Otolaryngol Head Neck Surg. 1993;108(3):389-394.
23. Kaya S, et al. Mycological examination of ear discharge in patients with chronic otitis media: a prospective study. BMC Infect Dis. 2007;7:23.

Most read articles by the same author(s)